Detection of Flunitrazepam (Roofies) on Toxicology Screens
Flunitrazepam (Rohypnol) is not identified in routine tests for benzodiazepines and requires specialized testing methods for detection. 1, 2, 3
Key Facts About Flunitrazepam Detection
- Standard drug-screening panels do not include flunitrazepam, making it impossible to detect through routine toxicology screens 1
- Flunitrazepam has a very limited detection window - approximately 24 hours in blood and up to 48 hours in urine after ingestion 3, 4
- When specifically testing for flunitrazepam, it would be listed as "flunitrazepam" or its major metabolite "7-aminoflunitrazepam" on specialized confirmatory testing 5, 6
- Flunitrazepam is rarely detected in sexual assault cases - studies show it's confirmed in only about 0.33% of suspected drug-facilitated sexual assault cases 1
- If flunitrazepam is suspected, toxicology screening should be performed immediately, even before completing history and physical examination 1
Detection Methods and Challenges
Specialized testing methods required for flunitrazepam detection include:
Common pitfalls in detection:
Clinical Implications
When flunitrazepam exposure is suspected, healthcare providers should:
- Collect samples immediately (first urine produced after suspected exposure is ideal) 1
- Consult with toxicologists or sexual assault centers about proper collection methods 1
- Request specific testing for flunitrazepam and 7-aminoflunitrazepam 5, 6
- Consider testing for other substances commonly used in sexual assault (alcohol, GHB, other benzodiazepines, antihistamines) 2
If a general toxicology screen is positive, the same sample should be sent for confirmatory testing using gas chromatography or mass spectroscopy 1
Be aware that flunitrazepam use may be more common in geographic areas where it is legal or more accessible (e.g., Mexico and border areas) 1